Logo image of BXS

Bancorpsouth Inc (BXS) Stock Fundamental Analysis

NYSE:BXS - New York Stock Exchange, Inc. -

28.76  -0.31 (-1.07%)

After market: 29.15 +0.39 (+1.36%)

Fundamental Rating

3

BXS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 394 industry peers in the Banks industry. BXS may be in some trouble as it scores bad on both profitability and health. BXS is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BXS was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 1.09%
ROE 9.76%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BXS does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 28.16%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

There is no outstanding debt for BXS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

BXS has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.37% over the past year.
The Earnings Per Share has been growing by 8.60% on average over the past years. This is quite good.
Looking at the last year, BXS shows a small growth in Revenue. The Revenue has grown by 7.16% in the last year.
Measured over the past years, BXS shows a small growth in Revenue. The Revenue has been growing by 7.67% on average per year.
EPS 1Y (TTM)31.37%
EPS 3Y9.17%
EPS 5Y8.6%
EPS Q2Q%-7.02%
Revenue 1Y (TTM)7.16%
Revenue growth 3Y11.46%
Revenue growth 5Y7.67%
Sales Q2Q%7.75%

3.2 Future

Based on estimates for the next years, BXS will show a very strong growth in Earnings Per Share. The EPS will grow by 21.73% on average per year.
The Revenue is expected to grow by 22.94% on average over the next years. This is a very strong growth
EPS Next Y-24.48%
EPS Next 2Y8.72%
EPS Next 3Y12.27%
EPS Next 5Y21.73%
Revenue Next Year16.52%
Revenue Next 2Y31.05%
Revenue Next 3Y21.45%
Revenue Next 5Y22.94%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BXS Yearly Revenue VS EstimatesBXS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
BXS Yearly EPS VS EstimatesBXS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.73 indicates a reasonable valuation of BXS.
When comparing the Price/Earnings ratio of BXS to the average of the S&P500 Index (27.50), we can say BXS is valued rather cheaply.
With a Price/Forward Earnings ratio of 11.26, the valuation of BXS can be described as very reasonable.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, BXS is valued rather cheaply.
Industry RankSector Rank
PE 10.73
Fwd PE 11.26
BXS Price Earnings VS Forward Price EarningsBXS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BXS Per share dataBXS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

BXS's earnings are expected to grow with 12.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)1.25
EPS Next 2Y8.72%
EPS Next 3Y12.27%

More info and screens

5

5. Dividend

5.1 Amount

BXS has a Yearly Dividend Yield of 2.78%.
BXS's Dividend Yield is comparable with the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 2.78%

5.2 History

On average, the dividend of BXS grows each year by 14.77%, which is quite nice.
BXS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)14.77%
Div Incr YearsN/A
Div Non Decr YearsN/A
BXS Yearly Dividends per shareBXS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 0.2 0.4 0.6

5.3 Sustainability

29.41% of the earnings are spent on dividend by BXS. This is a low number and sustainable payout ratio.
The dividend of BXS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP29.41%
EPS Next 2Y8.72%
EPS Next 3Y12.27%
BXS Dividend Payout.BXS Dividend Payout, showing the Payout Ratio.BXS Dividend Payout.PayoutRetained Earnings

More info and screens

Bancorpsouth Inc

NYSE:BXS (10/28/2021, 8:28:46 PM)

After market: 29.15 +0.39 (+1.36%)

28.76

-0.31 (-1.07%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-25 2021-10-25
Earnings (Next)N/A N/A
Inst Owners0.69%
Inst Owner Change0%
Ins Owners2.3%
Ins Owner Change0%
Market Cap2.95B
Analysts85.8
Price Target34.73 (20.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.78%
Yearly Dividend0.8
Dividend Growth(5Y)14.77%
DP29.41%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.73
Fwd PE 11.26
P/S 2.77
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB N/A
EV/EBITDA N/A
EPS(TTM)2.68
EY9.32%
EPS(NY)2.55
Fwd EY8.88%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.37
BVpS29.9
TBVpSN/A
PEG (NY)N/A
PEG (5Y)1.25
Profitability
Industry RankSector Rank
ROA 1.09%
ROE 9.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 28.16%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.37%
EPS 3Y9.17%
EPS 5Y8.6%
EPS Q2Q%-7.02%
EPS Next Y-24.48%
EPS Next 2Y8.72%
EPS Next 3Y12.27%
EPS Next 5Y21.73%
Revenue 1Y (TTM)7.16%
Revenue growth 3Y11.46%
Revenue growth 5Y7.67%
Sales Q2Q%7.75%
Revenue Next Year16.52%
Revenue Next 2Y31.05%
Revenue Next 3Y21.45%
Revenue Next 5Y22.94%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A